Boston Fair Value
BS
The fair market value of BSXC.VI stock is 74.64 EUR. Relative to the market price of 86 EUR Boston is overvalued by 11.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Boston Valuation
Current BSXC.VI share ticker price is 86 EUR.
The fair value level of 74.64 EUR can be considered as an effective entry point for long-term investors to start investing in BSXC.VI stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 13% higher its fair value
Current price is 81% higher its minimum value
Current price is 32% lower its maximum value
Market price:
BSXC.VI stock is overvalued
It means the current price may concern as a Risky Entry Point
Boston Scientific Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
98.05
2
Median P/E over 5 years
64.35
3
Minimum P/E over 5 years
14.12
4
Earning per share (last 12 months)
1.22 USD
Maximum value
1
x
4
=
113.73 EUR
Fair value
2
x
4
=
74.64 EUR
Minimum value
3
x
4
=
16.38 EUR
Boston Scientific Corp price metrics
15.54
Annual return (geometric mean)
28.12
Risk (standard deviation) of returns
β
0.75
Beta (volatility compared to market)